TITLE

Increase in Sexual Risk Behavior Associated with Immunologic Response to Highly Active Antiretroviral Therapy among HIV-Infected Injection Drug Users

AUTHOR(S)
Tun, Waimar; Gange, Stephen J.; Vlahov, David; Strathdee, Steffanie A.; Celentano, David D.
PUB. DATE
April 2004
SOURCE
Clinical Infectious Diseases;4/15/2004, Vol. 38 Issue 8, p1167
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This study identifies factors associated with high-risk sexual and drug injection behaviors among human immunodeficiency virus (HIV)-infected injection drug users (IDUs) after initiation of highly active antiretroviral therapy (HAART). Participants of a large cohort study of IDUs in Baltimore were seen at semiannual visits; blood samples to determine HIV serostatus and CD4+ cell count were obtained, as well as questionnaire data on risk behaviors and medication. Survival analysis conducted for 190 HIV-infected participants who initiated HAART during 1996-2000 revealed that an increase in CD4+ cell count (categorized as an increase of >0 cells/mm³ or of CO cells/mm³) after HAART initiation was independently associated with engaging in any sexual intercourse (adjusted relative hazard [ARH], 1.83; 95% CI, 1.22-2.73) and with a 3-fold increase in the hazard of engaging in unprotected sexual intercourse (ARH, 3.29; 95% CI, 1.57-6.93) after HAART initiation. An increase in CD4+ cell count after HAART initiation was not associated with injection of drugs or needle sharing. Risk reduction counseling remains important, despite improvements in the treatment of HIV infection.
ACCESSION #
13015208

 

Related Articles

  • Simple, Effective Interventions Are Key to Improving Adherence in Marginalized Populations. Mills, Edward J.; Cooper, Curtis // Clinical Infectious Diseases;10/1/2007, Vol. 45 Issue 7, p916 

    The article presents the authors' view on the article "Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: A marginal structural model analysis," by M.L. Petersen and colleagues. The association between pillbox use and both improved...

  • Immune Reconstitution Hepatitis in HIV and Hepatitis B Coinfection, Despite Lamivudine Therapy as Part of HAART. Drake, Anne; Mijch, Anne; Sasadeusz, Joe // Clinical Infectious Diseases;7/1/2004, Vol. 39 Issue 1, p129 

    Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection occurs commonly. The introduction of antiretroviral therapy can result in immune reconstitution hepatitis. We describe 2 coinfected patients who developed clinical flares of HBV disease, despite the inclusion of...

  • Desperately seeking targets: the ethics of routine HIV testing in low-income countries. Rennie, Stuart; Behets, Frieda // Bulletin of the World Health Organization;Jan2006, Vol. 84 Issue 1, p52 

    The human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) pandemic, and responses to it, have exposed clear political, social and economic inequities between and within nations. The most striking manifestations of this inequity is access to AIDS treatment. In affluent...

  • Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme. Anaky, M.-F.; Duvignac, J.; Wemin, L.; Kouakoussui, A.; Karcher, S.; Touré, S.; Seyler, C.; Fassinou, P.; Dabis, F.; N'Dri-Yoman, T.; Anglaret, X.; Leroy, V. // Bulletin of the World Health Organization;Jul2010, Vol. 88 Issue 7, p490 

    Objective To investigate deaths and losses to follow-up in a programme designed to scale up antiretroviral therapy (ART) for HIV- infected children in Côte d'Ivoire. Methods Between 2004 and 2007, HIV-exposed children at 19 centres were offered free HIV serum tests (polymerase chain reaction...

  • How to Start Antiretroviral Therapy? Horster, S.; Goebel, F.-D. // Infection;Jun2004, Vol. 32 Issue 3, p184 

    The article presents information about antiretroviral therapy (ART). Whenever started, ART should undoubtedly provide suppression of HIV replication, that is, plasma HIV-RNA below limit of detection for the longest time period possible. First attempts to meet this demand had been made with...

  • tipranavir.  // Davis's Drug Guide for Nurses, 10th edition;2007, p1152 

    This article presents a nurse's guide to the antiretroviral agent tipranavir. Tipranavir is indicated for advanced HIV disease resistant to other anti-HIV therapies. Tipranavir works by inhibiting the processing of viral polyproteins, preventing formation of mature virions. Its therapeutic...

  • Measuring adherence to antiretroviral treatment and assessing factors affecting adherence in a state primary healthcare clinic, Mitchells Plain Community Health Centre. Engel, T.; Schlemmer, A. C. // South African Family Practice;Feb/Mar2012, Vol. 54 Issue 1, p77 

    Background: A need was identified to measure adherence levels to antiretroviral treatment (ART) in a resource-poor setting and to assess the impact on adherence to ART of partner disclosure, partner support, other support, and length of time between diagnosis and ART commencement. Method: A...

  • HIV entry inhibitors: a new generation of antiretroviral drugs. Krambovitis, Elias; Porichis, Filippos; Spandidos, Demetrios A // Acta Pharmacologica Sinica;Oct2005, Vol. 26 Issue 10, p1165 

    AIDS is presently treatable, and patients can have a good prognosis due to the success of highly active antiretroviral therapy (HAART), but it is still not curable or preventable. High toxicity of HAART, and the emergence of drug resistance add to the imperative to continue research into new...

  • HIV/AIDS: Recent Advances in Antiretroviral Agents. Nikolopoulos, Georgios; Bonovas, Stefanos; Tsantes, Argirios; Sitaras, Nikolaos M. // Mini Reviews in Medicinal Chemistry;Jul2009, Vol. 9 Issue 8, p900 

    Despite the considerable progress in antiretroviral therapy, the eradication of HIV-1 remains unfeasible. Therefore, novel agents are under investigation. The aim of this review is to summarize the conventional compounds, to describe the recently approved agents, and to take a comprehensive look...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics